- Markets
- Healthcare
- ALPA
ALPA
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Air Canada And ALPA Reach Tentative Agreement On A New Four-Year Contract
Sept 15 (Reuters) - Air Canada AC.TO:
AIR CANADA AND ALPA REACH TENTATIVE AGREEMENT ON A NEW FOUR-YEAR CONTRACT
AIR CANADA - TERMS OF NEW AGREEMENT WILL REMAIN CONFIDENTIAL PENDING A RATIFICATION VOTE BY MEMBERSHIP, EXPECTED TO BE COMPLETED OVER NEXT MONTH
AIR CANADA - AIR CANADA AND AIR CANADA ROUGE WILL CONTINUE TO OPERATE AS NORMAL
Source text for Eikon: ID:nCNW2ShNga
Further company coverage: AC.TO
(([email protected];))
Sept 15 (Reuters) - Air Canada AC.TO:
AIR CANADA AND ALPA REACH TENTATIVE AGREEMENT ON A NEW FOUR-YEAR CONTRACT
AIR CANADA - TERMS OF NEW AGREEMENT WILL REMAIN CONFIDENTIAL PENDING A RATIFICATION VOTE BY MEMBERSHIP, EXPECTED TO BE COMPLETED OVER NEXT MONTH
AIR CANADA - AIR CANADA AND AIR CANADA ROUGE WILL CONTINUE TO OPERATE AS NORMAL
Source text for Eikon: ID:nCNW2ShNga
Further company coverage: AC.TO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Alpa Lab do?
Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified pharmaceutical company in Central India. Since 1967, it has been manufacturing a wide range of quality Pharmaceutical Finished Dosage Forms for human and veterinary use.
Who are the competitors of Alpa Lab?
Alpa Lab major competitors are Coral Laboratories, Kimia Biosciences, Panchsheel Organics, Krebs Biochem.&Inds, Ambalal Sarabhai Ent, Trident Lifeline, Gennex Lab. Market Cap of Alpa Lab is ₹233 Crs. While the median market cap of its peers are ₹250 Crs.
Is Alpa Lab financially stable compared to its competitors?
Alpa Lab seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Alpa Lab pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Alpa Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Alpa Lab allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances
How strong is Alpa Lab balance sheet?
Balance sheet of Alpa Lab is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Alpa Lab improving?
Yes, profit is increasing. The profit of Alpa Lab is ₹25.24 Crs for TTM, ₹16.78 Crs for Mar 2024 and ₹12.58 Crs for Mar 2023.
Is the debt of Alpa Lab increasing or decreasing?
Yes, The debt of Alpa Lab is increasing. Latest debt of Alpa Lab is ₹2.15 Crs as of Sep-24. This is greater than Mar-24 when it was ₹1.89 Crs.
Is Alpa Lab stock expensive?
Alpa Lab is not expensive. Latest PE of Alpa Lab is 9.25, while 3 year average PE is 14.44. Also latest EV/EBITDA of Alpa Lab is 29.02 while 3yr average is 34.5.
Has the share price of Alpa Lab grown faster than its competition?
Alpa Lab has given better returns compared to its competitors. Alpa Lab has grown at ~34.16% over the last 2yrs while peers have grown at a median rate of 33.28%
Is the promoter bullish about Alpa Lab?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Alpa Lab is 57.29% and last quarter promoter holding is 57.29%.
Are mutual funds buying/selling Alpa Lab?
There is Insufficient data to gauge this.